CIGI Stock Analysis: Colliers International Bats | NASDAQ
Real Estate Services | NASDAQ, USA | Market Cap: 4.401m USD | 12M Return: -41.4% | CA1946931070 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 22.3M
EPS Trend: 90.3%
Qual. Beats: 0
Rev. Trend: 98.3%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Colliers International Group Inc. (NASDAQ: CIGI) is a Toronto-based commercial real estate services firm founded in 1972, operating across North America, Europe, Asia-Pacific, and other international markets. The company operates through three primary business lines: commercial real estate services (including capital markets, landlord and tenant representation, and property/lease administration), engineering and project management (covering infrastructure, environmental, and construction services), and investment management (offering perpetual funds, long-dated funds, and separately managed accounts).
As a mid-cap company in the GICS Real Estate sector (Real Estate Development sub-industry), Colliers follows a diversified professional services model rather than a traditional property ownership strategy, generating revenue primarily through advisory fees, transaction commissions, outsourced facility management contracts, and asset management fees. The firm has expanded its global footprint through a combination of organic growth and acquisitions, making it one of the larger non-franchised alternatives to the major brokerage firms in the commercial real estate services space.
- Capital Markets revenue declines with elevated interest rates
- Engineering segment margins expand on infrastructure spending
- Outsourcing revenue grows providing recurring income stability
| Net Income: 109.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.26 > 1.0 |
| NWC/Revenue: 22.13% < 20% (prev 4.93%; Δ 17.20% < -1%) |
| CFO/TA 0.04 > 3% & CFO 296.0m > Net Income 109.2m |
| Net Debt (3.61b) to EBITDA (665.5m): 5.43 < 3 |
| Current Ratio: 5.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (36.7m) vs 12m ago -1.71% < -2% |
| Gross Margin: 27.01% > 18% (prev 35.31%; Δ -8.30% > 0.5%) |
| Asset Turnover: 83.58% > 50% (prev 80.32%; Δ 3.26% > 0%) |
| Interest Coverage Ratio: 4.18 > 6 (EBIT TTM 395.8m / Interest Expense TTM 94.7m) |
| A: 0.17 (Total Current Assets 1.63b - Total Current Liabilities 302.9m) / Total Assets 7.94b |
| B: -0.01 (Retained Earnings -101.6m / Total Assets 7.94b) |
| C: 0.05 (EBIT TTM 395.8m / Avg Total Assets 7.20b) |
| D: 0.30 (Book Value of Equity 1.54b / Total Liabilities 5.09b) |
| Altman-Z'' = 1.75 = BBB |
| DSRI: 1.07 (Receivables 1.32b/1.06b, Revenue 6.02b/5.19b) |
| GMI: 1.31 (GM 35.31% / 27.01%) |
| AQI: 1.10 (AQ_t 0.69 / AQ_t-1 0.63) |
| SGI: 1.16 (Revenue 6.02b / 5.19b) |
| TATA: -0.02 (NI 109.2m - CFO 296.0m) / TA 7.94b) |
| Beneish M = -2.52 (Cap -4..+1) = A |
As of October 17, 2026, the stock is trading at USD 90.32 with a total of 145,914 shares traded. Over the past week, the price has changed by +4.30%, over one month by +1.32%, over three months by -11.63% and over the past year by -41.42%.
Current recommended Stop Loss: 86.50 (which is 4.2% or 1.3 ATR below the current price).
Colliers International Bats has received a consensus analysts rating of 4.08. Therefore, it is recommended to buy CIGI.
- StrongBuy: 5
- Buy: 4
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 137.2 | 51.9% |
P/E Trailing = 40.6179
P/E Forward = 10.929
P/S = 0.7389
P/B = 3.0249
P/EG = 1.2156
Revenue TTM = 6.02b USD
EBIT TTM = 395.8m USD
EBITDA TTM = 665.5m USD
Long Term Debt = 2.49b USD (from longTermDebt, last quarter)
Short Term Debt = 302.9m USD (from shortTermDebt, last quarter)
Debt = 3.93b USD (from shortLongTermDebtTotal, last quarter) + Leases 625.1m
Net Debt = 3.61b USD (calculated: Debt 3.93b - CCE 318.6m)
Enterprise Value = 8.02b USD (4.40b + Debt 3.93b - CCE 318.6m)
Interest Coverage Ratio = 4.18 (Ebit TTM 395.8m / Interest Expense TTM 94.7m)
EV/FCF = 24.18x (Enterprise Value 8.02b / FCF TTM 331.5m)
FCF Yield = 4.14% (FCF TTM 331.5m / Enterprise Value 8.02b)
FCF Margin = 5.51% (FCF TTM 331.5m / Revenue TTM 6.02b)
Net Margin = 1.81% (Net Income TTM 109.2m / Revenue TTM 6.02b)
Gross Margin = 27.01% ((Revenue TTM 6.02b - Cost of Revenue TTM 4.39b) / Revenue TTM)
Gross Margin QoQ = 40.39% (prev 29.54%)
Tobins Q-Ratio = 1.01 (Enterprise Value 8.02b / Total Assets 7.94b)
Interest Expense / Debt = 2.41% (Interest Expense 94.7m / Debt 3.93b)
Taxrate = 28.64% (86.2m / 301.1m)
NOPAT = 282.5m (EBIT 395.8m * (1 - 28.64%))
Current Ratio = 1.70 (Total Current Assets 1.63b / Total Current Liabilities 963.1m)
Debt / Equity = 2.55 (Debt 3.93b / totalStockholderEquity, last quarter 1.54b)
Debt / EBITDA = 5.43 (Net Debt 3.61b / EBITDA 665.5m)
Debt / FCF = 10.90 (Net Debt 3.61b / FCF TTM 331.5m)
Total Stockholder Equity = 1.51b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.52% (Net Income 109.2m / Total Assets 7.94b)
RoE = 7.23% (Net Income TTM 109.2m / Total Stockholder Equity 1.51b)
RoCE = 9.91% (EBIT 395.8m / Capital Employed (Equity 1.51b + L.T.Debt 2.49b))
RoIC = 3.70% (NOPAT 282.5m / Invested Capital 7.64b)
WACC = 5.45% (E(4.40b)/V(8.33b) * Re(8.79%) + D(3.93b)/V(8.33b) * Rd(2.41%) * (1-Tc(0.29)))
Discount Rate = 8.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -61.86 | Cagr: -11.89%
[DCF] Terminal Value 74.66% ; FCFF base≈339.3m ; Y1≈324.9m ; Y5≈312.9m
[DCF] Fair Price = 26.18 (EV 4.92b - Net Debt 3.61b = Equity 1.30b / Shares 49.8m; r=8.35% [WACC [floored]]; 5y FCF grow -5.55% → 2.50% )
EPS Correlation: 90.25 | EPS CAGR: 9.44% | SUE: 0.47 | # QB: 0
Revenue Correlation: 98.32 | Revenue CAGR: 14.29% | SUE: 0.26 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.96 | Chg30d=-0.25% | Revisions=-8% | Analysts=10
EPS current Year (2026-12-31): EPS=7.50 | Chg30d=-0.13% | Revisions=+6% | GrowthEPS=+13.9% | GrowthRev=+15.5%
EPS next Year (2027-12-31): EPS=8.48 | Chg30d=-0.51% | Revisions=+64% | GrowthEPS=+13.1% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +25% (up=21, down=12)